These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions. Sörgel F, Kinzig M. Am J Med; 1993 Mar 22; 94(3A):56S-69S. PubMed ID: 8383921 [Abstract] [Full Text] [Related]
9. Indomethacin/ibuprofen-like anti-inflammatory agents selectively potentiate the gamma-aminobutyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on [35S]t-butylbicyclophosphorothionate binding. Squires RF, Saederup E. Mol Pharmacol; 1993 May 22; 43(5):795-800. PubMed ID: 8388990 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of the newer fluoroquinolones. Brouwers JR. Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S16-22. PubMed ID: 3325926 [Abstract] [Full Text] [Related]
14. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Akahane K, Sekiguchi M, Une T, Osada Y. Antimicrob Agents Chemother; 1989 Oct 11; 33(10):1704-8. PubMed ID: 2556076 [Abstract] [Full Text] [Related]